These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38020149)

  • 41. Estimated Loss of Lifetime Employment Duration for Patients Undergoing Maintenance Dialysis in Taiwan.
    Chang YT; Wang F; Huang WY; Hsiao H; Wang JD; Lin CC
    Clin J Am Soc Nephrol; 2021 May; 16(5):746-756. PubMed ID: 33858826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-Effectiveness of Care Environments for Improving the Mental Health of Orphaned and Separated Children and Adolescents in Kenya.
    Wilson-Barthes M; Chrysanthopoulou SA; Atwoli L; Ayuku D; Braitstein P; Galárraga O
    J Ment Health Policy Econ; 2021 Jun; 24(2):31-41. PubMed ID: 34151779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lifetime survival and medical costs of lung cancer: a semi-parametric estimation from South Korea.
    Park HY; Hwang J; Kim DH; Jeon SM; Choi SH; Kwon JW
    BMC Cancer; 2020 Sep; 20(1):846. PubMed ID: 32883237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.
    Yadav S; Delau O; Bonner AJ; Markovic D; Patterson W; Ottey S; Buyalos RP; Azziz R
    Elife; 2023 Aug; 12():. PubMed ID: 37534878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of healthcare resource utilization and medical costs between patients with seropositive and seronegative rheumatoid arthritis.
    Kim H; Cho SK; Choi S; Im SG; Jung SY; Jang EJ; Sung YK
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X211024830. PubMed ID: 34262621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Savings of loss-of-life expectancy and lifetime medical costs from prevention of spinal cord injuries: analysis of nationwide data followed for 17 years.
    Lien WC; Wang WM; Wang F; Wang JD
    Inj Prev; 2021 Dec; 27(6):567-573. PubMed ID: 33483326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis.
    Simpson E; Hock E; Stevenson M; Wong R; Dracup N; Wailoo A; Conaghan P; Estrach C; Edwards C; Wakefield R
    Health Technol Assess; 2018 Apr; 22(20):1-258. PubMed ID: 29712616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data.
    Strand V; Shah R; Atzinger C; Zhou J; Clewell J; Ganguli A; Tundia N
    Curr Med Res Opin; 2020 Jan; 36(1):161-168. PubMed ID: 31433680
    [No Abstract]   [Full Text] [Related]  

  • 50. Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study.
    Bergman M; Zhou L; Patel P; Sawant R; Clewell J; Tundia N
    Adv Ther; 2021 May; 38(5):2558-2570. PubMed ID: 33837497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimation of savings of life-years and cost from early detection of cervical cancer: a follow-up study using nationwide databases for the period 2002-2009.
    Hung MC; Liu MT; Cheng YM; Wang JD
    BMC Cancer; 2014 Jul; 14():505. PubMed ID: 25011933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Finding Rheumatoid Arthritis Impact on Life (FRAIL Study): economic burden.
    Miranda LC; Santos H; Ferreira J; Coelho P; Silva C; Saraiva-Ribeiro J;
    Acta Reumatol Port; 2012; 37(2):134-42. PubMed ID: 23149635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Demographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis.
    Wu B; Deshpande G; Gu T; Popelar B; Philbin M; Wan GJ
    J Med Econ; 2017 Nov; 20(11):1170-1177. PubMed ID: 28760047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimation of lifetime productivity loss from patients with chronic diseases: methods and empirical evidence of end-stage kidney disease from Taiwan.
    Wang F; Hwang JS; Huang WY; Chang YT; Wang JD
    Health Econ Rev; 2024 Feb; 14(1):10. PubMed ID: 38319466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid Arthritis.
    Zhou ZY; Griffith J; Du EX; Chin D; Betts KA; Ganguli A
    Adv Ther; 2016 May; 33(5):807-23. PubMed ID: 27084724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does healthcare regime affiliation influence the clinical outcomes of patients with rheumatoid arthritis?
    Barahona-Correa JE; Flórez-Suárez J; Coral-Alvarado P; Méndez-Patarroyo P; Quintana-López G
    Clin Rheumatol; 2021 Mar; 40(3):877-886. PubMed ID: 32813188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trends in the first decade of 21st century healthcare utilisation in a rheumatoid arthritis cohort compared with the general population.
    Hagel S; Petersson IF; Bremander A; Lindqvist E; Bergknut C; Englund M
    Ann Rheum Dis; 2013 Jul; 72(7):1212-6. PubMed ID: 23223424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of Healthcare Utilization and Costs Between RA Patients Receiving Biological and Conventional Synthetic DMARDs: A Nationwide Population-Based Cohort Study in Taiwan.
    Chen DY; Yu F; Tuan LW; Tang CH
    Front Pharmacol; 2019; 10():1214. PubMed ID: 31695611
    [No Abstract]   [Full Text] [Related]  

  • 59. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand.
    Osiri M; Maetzel A; Tugwell P
    J Rheumatol; 2007 Jan; 34(1):57-63. PubMed ID: 17183621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and out-patient medical costs of comorbid conditions in patients with rheumatoid arthritis.
    Osiri M; Sattayasomboon Y
    Joint Bone Spine; 2013 Dec; 80(6):608-12. PubMed ID: 23827409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.